6.99
price up icon0.14%   0.00
after-market 시간 외 거래: 6.99
loading
전일 마감가:
$6.99
열려 있는:
$6.99
하루 거래량:
361.49K
Relative Volume:
0.19
시가총액:
$573.54M
수익:
$414.29M
순이익/손실:
$-99.81M
주가수익비율:
-5.2367
EPS:
-1.3348
순현금흐름:
$-28.65M
1주 성능:
+0.14%
1개월 성능:
+0.43%
6개월 성능:
+85.68%
1년 성능:
-27.08%
1일 변동 폭
Value
$6.99
$7.00
1주일 범위
Value
$6.98
$7.00
52주 변동 폭
Value
$3.08
$9.67

애콜레이드 Stock (ACCD) Company Profile

Name
명칭
Accolade Inc
Name
전화
610-834-2989
Name
주소
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Name
직원
2,400
Name
트위터
Name
다음 수익 날짜
2025-01-13
Name
최신 SEC 제출 서류
Name
ACCD's Discussions on Twitter

ACCD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Health Information Services icon
ACCD
Accolade Inc
6.99 573.54M 414.29M -99.81M -28.65M -1.3348
Health Information Services icon
VEEV
Veeva Systems Inc
226.50 37.08B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
DOCS
Doximity Inc
57.95 10.64B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
TEM
Tempus Ai Inc
49.89 8.13B 640.44M -743.28M -206.93M -11.29
Health Information Services icon
HQY
Healthequity Inc
88.74 7.54B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
37.33 6.36B 906.14M -52.62M 89.62M -0.3621

애콜레이드 Stock (ACCD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-06-28 재확인 Needham Buy
2024-02-26 개시 Leerink Partners Outperform
2024-01-17 재개 DA Davidson Neutral
2024-01-03 개시 Barclays Equal Weight
2023-05-24 업그레이드 BofA Securities Neutral → Buy
2023-04-12 개시 Stephens Overweight
2023-03-23 업그레이드 Guggenheim Neutral → Buy
2023-02-09 다운그레이드 Jefferies Buy → Hold
2023-02-02 개시 Raymond James Outperform
2022-09-08 재개 Piper Sandler Overweight
2022-09-07 개시 Truist Buy
2022-08-12 개시 DA Davidson Buy
2022-05-02 업그레이드 Wells Fargo Underweight → Equal Weight
2022-04-29 다운그레이드 BTIG Research Buy → Neutral
2022-04-29 다운그레이드 BofA Securities Buy → Neutral
2022-04-29 다운그레이드 Credit Suisse Outperform → Neutral
2022-04-29 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-04-29 다운그레이드 SVB Leerink Outperform → Mkt Perform
2022-04-11 개시 Wells Fargo Underweight
2022-04-07 개시 Guggenheim Neutral
2022-04-01 재개 Credit Suisse Outperform
2022-02-11 개시 Goldman Buy
2021-12-02 개시 Jefferies Buy
2021-09-30 개시 Berenberg Buy
2021-09-17 업그레이드 Robert W. Baird Neutral → Outperform
2021-05-28 개시 Robert W. Baird Neutral
2021-05-06 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-04-15 개시 Needham Buy
2021-03-11 재개 Goldman Buy
2021-01-15 업그레이드 Credit Suisse Neutral → Outperform
2021-01-07 개시 BTIG Research Buy
2020-12-08 개시 Canaccord Genuity Buy
2020-09-22 개시 DA Davidson Buy
2020-07-27 개시 BofA Securities Buy
2020-07-27 개시 Credit Suisse Neutral
2020-07-27 개시 Goldman Buy
2020-07-27 개시 Morgan Stanley Overweight
2020-07-27 개시 Piper Sandler Overweight
2020-07-27 개시 Robert W. Baird Outperform
2020-07-27 개시 SVB Leerink Outperform
모두보기

애콜레이드 주식(ACCD)의 최신 뉴스

pulisher
Mar 30, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD) - ACCESS Newswire

Mar 30, 2025
pulisher
Mar 29, 2025

Is Accolade Inc. (NASDAQ:ACCD) the Best Performing Stock So Far In 2025? - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD) - ACCESS Newswire

Mar 28, 2025
pulisher
Mar 27, 2025

Accolade shareholders approve merger with Transcarent By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade Stockholders Approve Merger with Transcarent - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade Shareholders Greenlight Merger With Transcarent - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade shareholders approve merger with Transcarent - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Major Healthcare Deal: Accolade Shareholders Green-Light Transcarent Merger as Company Plans Private Future - Stock Titan

Mar 27, 2025
pulisher
Mar 21, 2025

GLAZER CAPITAL, LLC Acquires Significant Stake in Accolade Inc - GuruFocus

Mar 21, 2025
pulisher
Mar 19, 2025

Accolade president Robert Cavanaugh sells $1,264 in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CFO Stephen H. Barnes sells $991 worth of stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CEO Rajeev Singh sells $2,018 in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade president Robert Cavanaugh sells $1,264 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CEO Rajeev Singh sells $2,018 in stock - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Accolade CFO Stephen H. Barnes sells $991 worth of stock - Investing.com

Mar 19, 2025
pulisher
Mar 14, 2025

STOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of ACCD, SKGR, AVAV, WMPN to Act Now - The Malaysian Reserve

Mar 14, 2025
pulisher
Mar 13, 2025

Do Options Traders Know Something About Accolade (ACCD) Stock We Don't? - Barchart

Mar 13, 2025
pulisher
Mar 12, 2025

AcCOLADE CFO Stephen Barnes sells $1,769 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Accolade Inc Stock: $621M Transcarent Buyout Sends Shares Soaring - sharewise

Mar 12, 2025
pulisher
Mar 12, 2025

Accolade president Robert Cavanaugh sells shares worth $1,734 By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ACCD, SKGR, AVAV, WMPN to Act Now - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 12, 2025

AcCOLADE CFO Stephen Barnes sells $1,769 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Accolade president Robert Cavanaugh sells shares worth $1,734 - Investing.com

Mar 12, 2025
pulisher
Mar 11, 2025

Accolade Being Investigated on Behalf of Accolade, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 09, 2025

Accolade, Inc. (NASDAQ:ACCD) Stake Boosted by Rhumbline Advisers - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Analysts Set Accolade, Inc. (NASDAQ:ACCD) Target Price at $6.51 - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Accolade (NASDAQ:ACCD) Cut to “Hold” at Piper Sandler - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Accolade Welcomes Oshi Health to Trusted Partner Ecosystem – Company Announcement - Financial Times

Mar 06, 2025
pulisher
Mar 06, 2025

Can This Virtual GI Care Partnership Solve the $136B Digestive Health Crisis? - Stock Titan

Mar 06, 2025
pulisher
Mar 05, 2025

Accolade president Robert Cavanaugh sells $3,828 in stock - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade CEO Rajeev Singh sells $7,802 in company stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade’s CFO sells $3,577 in stock to cover tax obligations By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade EVP Richard Eskew sells $2,623 in company stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade CEO Rajeev Singh sells $7,802 in company stock - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade president Robert Cavanaugh sells $3,828 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Piper Sandler downgrades Accolade ahead of shareholder vote - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade EVP Richard Eskew sells $2,623 in company stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Piper Sandler downgrades Accolade ahead of shareholder vote By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Piper Sandler Downgrades Accolade to Neutral From Overweight, $9 Price Target -March 05, 2025 at 07:54 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade’s CFO sells $3,577 in stock to cover tax obligations - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Accolade, Crowdstrike, Marriott International - TradingView

Mar 05, 2025
pulisher
Mar 04, 2025

Piper Sandler Downgrades Accolade Inc. (ACCD) to Neutral - StreetInsider

Mar 04, 2025
pulisher
Mar 04, 2025

Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year? - Yahoo Finance

Mar 04, 2025

애콜레이드 (ACCD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

애콜레이드 주식 (ACCD) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Barnes Stephen H.
Chief Financial Officer
Mar 17 '25
Option Exercise
0.00
415
0
304,176
Barnes Stephen H.
Chief Financial Officer
Mar 18 '25
Sale
6.99
142
992
304,034
Cavanaugh Robert N
President
Mar 17 '25
Option Exercise
0.00
510
0
218,878
Cavanaugh Robert N
President
Mar 18 '25
Sale
6.99
181
1,264
218,697
$35.46
price up icon 0.54%
$4.57
price up icon 3.61%
$19.55
price up icon 0.36%
$22.36
price down icon 2.27%
$18.18
price up icon 1.34%
health_information_services WAY
$37.33
price up icon 1.06%
자본화:     |  볼륨(24시간):